Clinical trial
Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With…
NCT00113438 · Mateon Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00113438 |
|---|---|
| Title | Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors |
| Official title | A Randomized Open-Labeled Phase II Study of Combretastatin A-4 Phosphate in Combination With Paclitaxel and Carboplatin to Evaluate the Safety and Efficacy in Subjects With Advanced Imageable Malignancies |
| Lead sponsor | Mateon Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer, Tumor |
| Intervention type | Drug |
| Interventions | Combretastatin A-4 Phosphate + Paclitaxel + Carboplatin |
| Enrollment | 13 |
| Start date | Mar 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Jun 8, 2005 |
| Last update posted | Nov 1, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: